Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of PARP-1 Inhibitors.

Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of PARP-1 Inhibitors.
复制标题

使用肌苷单磷酸脱氢酶活性测定确定 PARP-1 抑制剂的特异性。

DOI:
10.1007/978-1-4939-6993-7_22
复制
发表时间:
2017
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
通讯作者:
Ji,Yingbiao
Ji,Yingbiao
中科院分区:
--
文献类型:
--
作者:
Anthony,Sajitha;Peterson,JeffreyR;Ji,Yingbiao

文献摘要

参考文献

相似文献

肌苷单磷酸脱氢酶(IMPDH)是一种参与嘌呤核苷酸生物合成的限速酶。它负责催化单磷酸肌苷(IMP)氧化成单磷酸黄嘌呤(XMP)。同时,辅因子NAD+被还原为NADH。聚(adp -核糖)聚合酶1 (PARP-1)也利用NAD+作为底物合成聚(adp -核糖)。研究表明,抑制PARP-1活性是一种有效的癌症治疗方法。然而,大多数PARP-1抑制剂,包括奥拉帕尼,都是作为NAD+类似物开发的。因此,这些抑制剂可能会干扰其他依赖NAD+的途径,如参与从头嘌呤代谢的途径。在本章中,我们描述了一种利用产物NADH的自身荧光定量测量IMPDH活性的方法。我们用这种方法分析了奥拉帕尼和非nad +样PARP-1抑制剂(5F02)对IMPDH活性的影响。我们发现,与5F02不同,奥拉帕尼以剂量依赖性的方式显著抑制IMPDH活性。我们的结果表明,IMPDH抑制是奥拉帕尼治疗的脱靶效应。这种影响的后果应在未来的临床研究中加以解决。
Inosine monophosphate dehydrogenase (IMPDH) is a rate-limiting enzyme involved in purine nucleotide biosynthesis. It is responsible for catalyzing the oxidation of inosine monophosphate (IMP) into xanthosine monophosphate (XMP). Concurrently, the cofactor NAD+is reduced to NADH. Poly(ADP-ribose) polymerase 1 (PARP-1) also utilizes NAD+as a substrate to synthesize poly(ADP-ribose). It has been demonstrated that inhibition of PARP-1 activity can be an effective cancer therapeutic. However, most PARP-1 inhibitors, including olaparib, were developed as NAD+analogs. Therefore, these inhibitors likely interfere with other NAD+-dependent pathways such as the one involved in de novo purine metabolism. In this chapter, we describe a method to quantitatively measure IMPDH activity by taking advantage of the autofluorescence of the product NADH. We use this method to analyze the effects of olaparib and non-NAD+-like PARP-1 inhibitor (5F02) on IMPDH activity. We found that olaparib, unlike 5F02, significantly inhibits IMPDH activity in a dose-dependent manner. Our results suggest that IMPDH inhibition is an off-target effect of olaparib treatment. The consequences of this effect should be addressed by future clinical studies.
DOI: 10.1016/j.gde.2010.06.001
发表时间: 2010-10
影响因子: 4
作者:
Ji, Yingbiao;Tulin, Alexei V.
通讯作者: Tulin, Alexei V.